Cu(II), Fe(III)与人血清白蛋白相互作用的荧光光谱研究

通过研究Cu(II),Fe(III)对人血清白蛋白(HSA)内源荧光的猝灭,探讨了Cu(II),Fe(III)与人血清白蛋白的结合机理。基于Forster非辐射能量转移机理。获得了人血清白蛋白第一类Cu(II)结合部位与214位色氨酸残基间的距离为1.8nm,并讨论了Cu(II),Fe(III)与HSA结合的差异。     

Cu(Ⅱ),Fe(Ⅲ)与人血清白蛋白相互作用的荧光光谱研究

通过研究Cu(Ⅱ),Fe(Ⅲ)对人血清白蛋白(HSA)内源荧光的猝灭,探讨了Cu(Ⅱ),Fe(Ⅲ)与人血清白蛋白的结合机理.基于Forster非辐射能量转移机理.获得了人血清白蛋白第一类Cu(Ⅱ)结合部位与214位色氨酸残基间的距离为1.8nm,并讨论了Cu(Ⅱ),Fe(Ⅲ)与HSA结合的差异.     

光谱法研究绿原酸与人血清白蛋白的相互作用

利用荧光光谱法研究了绿原酸与人血清白蛋白(HSA)的相互作用,考察了不同温度下绿原酸与HSA的结合常数KA和结合位点数n,并研究了Cu2+、Al3+、Ca2+、Pb2+等金属离子对绿原酸与HSA结合性质的影响。基于Frster偶极-偶极非辐射能量转移机理确定了荧光给体HSA与受体绿原酸间的结合距离。     

分子光谱法研究美他环素与人血清白蛋白的相互作用

用荧光、紫外等分子光谱法研究了美他环素(MC)与人血清白蛋白(HSA)的相互作用,考察了不同温度下MC与HSA的结合常数KA和结合位点数n,同时研究了Cu2+,Al3+,Pb2+,Ca2+和K+等金属离子对MC与HSA的结合性质的影响.基于F rster偶极-偶极非辐射能量转移机理确定了荧光给体HSA与受体MC间的结合距离.     

La（III）与HSA或BSA的结合平衡研究

用平衡透析法详细研究了pH=6.3条件十La(III)与HSA或BSA的结合平衡,Scatchard图分析表明,La(III)在HSA中有2个强结合部位和8个弱结合部位,在BSA中有2个强结合部位和6个弱结合部位,从La(III)与Cu(II),Zn(II)和Cd(II)等的竞争结合HSA或BSA的结果推测,La(III)在HSA或BSA中的一个强结合部位的配位原子可能全部是氧原子,通过非线性最小二乘法拟合Bjerum方程,首次报道了La(III)-HSA和La(III)-BSA体系的逐级稳定常数值,其K1的数量极为10^4,Hill系数及自由能偶合分析表明La(II)与HSA或BSA的结合产生一定的负协同效应。     

苦参碱Fe(Ⅲ)化合物的合成及其与HSA相互作用的光谱研究

采用具有天然抗肿瘤活性的药物苦参碱为配体,与Fe(III)反应得到黄色的离子型苦参碱Fe(III)化合物[H-Matrine][FeCl4],用X射线单晶衍射分析法确定了配合物的结构,并在模拟生理条件下,利用紫外光谱法、荧光光谱法、同步荧光光谱和圆二色谱法研究了化合物[H-Matrine][FeCl4]与人血清白蛋白(HSA)的相互作用。结果表明:[H-Matrine][FeCl4]对HSA的荧光产生猝灭作用,猝灭机制为静态猝灭;[H-Matrine][FeCl4]与HSA在不同温度下的结合常数K和结合位点数n,及其相关热力学参数ΔH、ΔG、ΔS,室温时分别为:1.03×106L·mol-1、1.24、-68.63KJ·mol、-34.30KJ·mol和114.05J·mol,且其相互作用力主要是静电作用力。同步荧光光谱的结果表明:[H-Matrine][FeCl4]与HSA的结合位点靠近色氨酸,并使色氨酸的疏水性减弱。     

黄芩素与人血清白蛋白相互作用的研究

在模拟人体生理条件下,利用荧光光谱法研究了黄芩素(Bcl)与人血清白蛋白(HSA)的相互作用。研究结果表明,黄芩素能够猝灭人血清白蛋白的内源荧光,其猝灭机理为静态猝灭。热力学参数ΔHθ(-70.8 kJ/mol),ΔSθ(-133 J·mol-1·K-1)的值均小于0,表明氢键和范德华力是维持基态复合物稳定性的主要作用力。位点竞争实验表明site I是黄芩素在HSA上的结合部位。三维荧光光谱实验结果表明黄芩素与人血清白蛋白相互作用后,改变了人血清白蛋白的构象。     

二苯甲酮与人血清白蛋白相互作用的研究

在模拟人体生理条件下(pH=7.4),采用荧光光谱、位点竞争、三维荧光光谱研究了二苯甲酮(BP)与人血清白蛋白(HSA)之间的相互作用。根据修正的Stern-Volmer方程计算了不同温度下的结合常数,并结合Van't Hoff方程计算出相应的热力学参数。实验结果表明,BP对HSA的猝灭机制为静态猝灭过程,氢键和范德华力是维持BP-HSA复合物稳定的主要作用力;位点竞争实验揭示了BP在HSA上的结合位点位于亚域结构II A上的疏水腔中(site I位);三维荧光光谱分析表明BP使HSA发生了轻微地解旋,HSA的二级结构发生了改变。     

人血清白蛋白与Cu(II)配合物的生物活性研究

Cu(II)配合物很有可能成为下一代的抗肿瘤药物。本文以2-氨基-5-氯苯酚和2-喹啉甲醛合成的席夫碱作为配体,与Cu(II)络合形成配合物1。分别对配合物1和其与人血清白蛋白(HSA)的复合物HSA-1进行体外抗肿瘤测试,发现HSA能提高配合物1的抗肿瘤活性,并降低了对正常细胞的毒性。通过线粒体膜电位等实验,可以推断出配合物1是通过线粒体通路诱导癌细胞凋亡。     

苦参碱Fe（III）化合物的合成及其与HSA相互作用的光谱研究

采用具有天然抗肿瘤活性的药物苦参碱为配体,与Fe( III)反应得到黄色的离子型苦参碱Fe( III)化合物[ H-Matrine][ FeCl4],用X射线单晶衍射分析法确定了配合物的结构,并在模拟生理条件下,利用紫外光谱法、荧光光谱法、同步荧光光谱和圆二色谱法研究了化合物[ H-Matrine][ FeCl4]与人血清白蛋白( HSA)的相互作用。结果表明：[ H-Matrine][ FeCl4]对 HSA的荧光产生猝灭作用,猝灭机制为静态猝灭;[ H-Matrine][ FeCl4]与HSA在不同温度下的结合常数K和结合位点数n,及其相关热力学参数ΔH、ΔG、ΔS,室温时分别为：1．03×106L·mol-1、1．24、-68．63KJ·mol、-34．30KJ·mol和114．05J·mol,且其相互作用力主要是静电作用力。同步荧光光谱的结果表明：[ H-Matrine][ FeCl4]与HSA的结合位点靠近色氨酸,并使色氨酸的疏水性减弱。     

4-Hydroxy-3,5-pyridinedicarboxylic Acids: Synthesis,Complexation Properties Towards Fe(III), Al(III), Cu(II), Zn(II), Human Serum Albumin,and Cellular Toxicity

4-hydroxy-3,5-pyridinedicarboxylic acid (DQ58) and 4-hydroxy-1-methyl-3,5-pyridinedicarboxylic acid (DQ71508) have been synthesized, and their Fe(III), Al(III), Cu(II), and Zn(II) coordination properties have been studied by potentiometry, UV–Vis spectroscopy (in the case of Fe(III), Al(III), Cu(II)), ¹H-NMR (for Al(III)) and EPR (for Cu(II)). The thermodynamic results were used to model the extent of the toxic metal ions decorporation (Fe(III) or Al(III)) in the presence of the essential metal ions (Cu(II) or Zn(II)). DQ58 and DQ71508 were demonstrated to interact with human serum albumin (HSA), which is assumed to be the main serum transporter of the chelators, and binding constants have been obtained by ultrafiltration. IC₅₀ values of 5.185 × 10^?3 and 1.033 × 10^?3 mol·L^?1 were collected after 24 and 48 h of treatment with DQ71508 towards human embryonic kidney HEK-293 cells, demonstrating the relatively low cytotoxicity of this compound. According to these results, both DQ58 and DQ71508 seem to be potential candidates for Fe chelation therapy, and DQ58 is a better Fe(III) chelator than DQ71508.     

Substitution Coordination Approach for Selective Determination of Complex: Pontachrome Violet SW/Fe(III)/Cu(II) System

The Substitution Coordination for Selective Determination (SCSD) was proposed by studying the complexations of pontachrome violet SW (PCV) with Fe(III) and Cu(II) at pH 5.5. The up dated approach to the de termination of binding constants of a complex was established by the spectral correction technique (SCT). The substitution complexation Cu(II) + Fe(PCV) → Cu(PCV) + Fe(III) has been applied to the direct selective determination of copper traces by the SCT with a high sensitivity.     

Organic acid solutions in the chromatography of inorganic ions VIII. Cation-exchange of Mn(II), Cd(II), Co(II), Ni(II), Zn(II), Cu(II), Fe(III), Sc(III), Y(III), Eu(III), Dy(III), Ho(III), Yb(III), Ti(IV) and Nb(V) in malate media

Summary The cation-exchange behaviour of Mn(II), Cd(II), Co(II), Ni(II), Zn(II), Cu(II), Fe(III), Sc(III), Y(III), Eu(III), Dy(III), Ho(III), Yb(III), Ti(IV) and Nb(V) in malate media at various concentrations and pH, was studied with Dowex 50 WX8 resin (200–400 mesh) in the ammonium form. Separation of Fe(III)/Cu(II), Fe(III)/Cu(II)/Zn(II), Fe(III)/Co(II)/Mn(II), Cu(II)/Ni(II)/Mn(II), Fe(III)/Cu(II)/Co(II)/Mn(II), Fe(III)/Cu(II)/Ni(II)/Cd(II), Yb(III)/Eu(III), Sc(III)/Y(III),Sc(III)/Yb(III)/Dy(III) and Nb(V)/Yb(III)/Ho(III) has been achieved, among others.This work was supported by C.N.R. of Italy.     

Human serum albumin interaction studies of a new copper(II) complex containing ceftobiprole drug using molecular modeling and multispectroscopic methods

A copper(II) complex containing the ceftobiprole drug and 1,10-phenanthroline (phen) has been synthesized and characterized by UV–vis, FT-IR and mass spectra, and elemental analysis. The binding interaction between [Cu(cef)(phen)Cl₂] complex and human serum albumin (HSA) was investigated using absorption, fluorescence emission and circular dichroism spectroscopies, and molecular docking. Thermodynamic parameters (ΔH < 0 and ΔS < 0) indicated that the hydrogen bond and van der Waals interactions played main roles in the binding of complex [Cu(cef)(phen)Cl₂] to HSA. The results of CD and UV–vis spectroscopy showed that the binding of [Cu(cef)(phen)Cl₂] to HSA induces some conformational changes in HSA. Displacement experiments predicted that the binding of [Cu(cef)(phen)Cl₂] complex to HSA is located within domain III, Sudlow’s site 2, and these observations were substantiated by molecular docking studies.     

Magnetic and EPR properties of Mn(II), Fe(III), Ni(II) and Cu(II) complexes of thiosemicarbazone of α-hydroxy-β-napthaldehyde

Mn(II), Fe(III), Ni(II) and Cu(II) complexes of the thiosemicarbazones of α-hydroxy-β-naphthaldehyde have been isolated. Ni(II) complex is diamagnetic, Cu(II) is planar involving metal-metal interactions, Mn(II) complex (μ_eff = 3.86B.M) has been assigned a planar structure with S = 3/2 while Fe(III) complex is five coordinated with S = 3/2.     

Compositions and structures of copper hexacyanoferrates(II) and (III): experimental results

The preparation, composition and structure of copper hexacyanoferrates have been investigated. Three methods were used: precipitation, local growth in an aqueous solution, and growth in a gel. Four compounds were obtained, either in powdered form or as single crystals: Cu(II)(2)Fe(II)(CN)(6) . xH(2)O, Cu(II)(3)[Fe(III)(CN)(6)](2) . xH(2)O, Na(2)Cu(II)Fe(II)(CN)(6) . 10H(2)O and K(2)Cu(II)Fe(II)(CN)(6). Powders of Cu(II)(2)Fe(II)(CN)(6) . xH(2)O and Cu(II)(3)[Fe(III) (CN)(6)](2) . xH(2)O are easily prepared by precipitation and can also be obtained by local growth. They crystallise generally with cubic symmetry, in space group Fm3m, and are structurally disordered. The mixed copper hexacyanoferrates of general formulae M(1)(2)Cu(II)Fe(II)(CN)(6) or M(I)Cu(II)Fe(III)(CN)(6) (here M(I) is Na, K) were not obtained by precipitation. The appropriate method was local growth for the preparation of powders of K(2)Cu(II)Fe(II)(CN)(6). Single crystals of Na(2)Cu(II)Fe(II)(CN)(6) were obtained by growth in a gel, and their study using single crystal X-ray diffraction revealed a new monoclinic structure.     

Synthesis,characterization and susceptibility of bacteria against Sulfamethoxydiazine complexes of copper(II), zinc(II), nickel(II), cadmium(II), chromium(III) and iron(III)

Complexes of sulfamethoxydiazine with Cu(II), Zn(II), Ni(II), Cd(II), Cr(III) and Fe(III) have been synthesized and characterized on the basis of conductivity measurements, elemental analyses, UV, IR, ¹H?NMR and thermal studies. It is shown that sulfamethoxydiazine behaves as a bidentate ligand, binding the metal ion through the sulfonyl oxygen and sulfonamide nitrogen. In vitro susceptibility tests of these complexes against Escherichia coli, Bacillus subtilis, Proteus vulgaris and Staphylococcus aureus were carried out. The results show that the antibacterial activities of the complexes of Zn(II), Cu(II), Cr(III) and Fe(III) are, in general, stronger than that of sulfamethoxydiazine, while the complexes of Cd(II) and Ni(II) are less active.     

Organic acid solutions in the chromatography of inorganic ions-IV: cation-exchange of Mn(II), Cd(II), Co(II), Ni(II), Cu(II), Al(III) and Fe(III) in tartrate media

The cation-exchange behaviour of Mn(II), Cd(II), Co(II), Ni(II), Cu(II), Al(III) and Fe(III), in tartaric acid media was studied. Separations of Fe(III), Cu(II), Ni(II), Co(II), Cd(II) and Mn(II) on Dowex 50W X8 have been achieved.     

Cd（Ⅱ）与HSA或BSA的结合平衡研究

用平衡透析法详细研究了生理pH(7.43)条件下Cd(Ⅱ)与HSA或BSA的结合平衡.通过非线性最小二乘法拟合Bjerrum方程,首次报道了Cd(Ⅱ)-HSA和Cd(Ⅱ)-BSA体系的逐级稳定常数值,其K_1～K_3的数量级均为10~4;Hill系数和自由能偶合定量分析表明Cd(Ⅱ)与HSA或BSA的结合均产生在类似体系中少见的强的正协同效应,且Cd(Ⅱ)与HSA结合产生的正协同效应大于BSA;Scatchard图分析表明,Cd(Ⅱ)在HSA和BSA中均有3个强结合部位.通过Cd(Ⅱ)与Cu(Ⅱ),Zn(Ⅱ)或Ca(Ⅱ)等竞争结合HSA或BSA的结果,进一步讨论了Cd(Ⅱ)在HSA或BSA中强结合部位的可能位置和(或)配体.     

Spectroscopic approach in characterization of chromium(III), manganese(II), iron(III) and copper(II) complexes with a nitrogen donor tetradentate, 14-membered azamacrocyclic ligand

The complexes of Cr(III), Mn(II), Fe(III) and Cu(II) were synthesized with the macrocyclic ligand i.e. 2,3,9,10-tetraketo-1,4,8,11-tetraazacyclotetradecane. The ligand was prepared by the [2 + 2] condensation reaction of diethyloxalate and 1,3-diamino propane. These complexes were found to have the general composition M(L)X3 and M'(L)X2 [where M = Mn(II) and Cu(II), M' = Cr(III) and Fe(III), L = ligand (N4) and X = Cl-, NO3-, 1/2SO4(2-) and [CH3COO-]. The ligand and its transition metal complexes were characterized by the elemental analyses, molar conductance, magnetic susceptibility, mass, IR, electronic, and EPR spectral studies. On the basis of IR, electronic and EPR spectral studies an octahedral geometry has been assigned for Cr(III), Mn(II) and Fe(III) and a tetragonal geometry for Cu(II) complexes.